Drug Development Resources
Three programs that are instrumental to drug development at Emory University and its application in the real world.
DRIVE
Emory formed DRIVE to advance the development of early-stage drug candidates to address viral diseases of global concern. DRIVE applies an entrepreneurial mindset and the focus of a biotechnology company to address the world’s need for therapies that end pandemics. By taking advantage of Emory’s renowned research enterprise, DRIVE increases the probability that promising drugs will be developed for the ultimate benefit of humanity.
EIDD
The Emory Institute for Drug Development, or EIDD, provides the multidisciplinary capabilities required to effectively advance cutting-edge drug discovery and development programs at the preclinical stage. EIDD is housed in state-of-the-art, fully equipped laboratory and office space that was specifically designed to support its dedicated teams focused on Medicinal and Process Chemistry, Virology and Molecular Biology, Bioanalytical Chemistry, Drug Metabolism, and Pharmacokinetics.
Office of Technology Transfer
The Office of Technology Transfer is responsible for negotiating industry clinical trial agreements, research agreements, and confidentiality agreements. Emory’s OTT is a hub of activity around research and innovation, with a world-class product pipeline. There are hundreds of innovations received from Emory’s renowned faculty that the OTT shepherds from the lab bench into the hands of a commercial partner. OTT serves as a single point of contact for industry, with focused outreach to companies looking to partner with Emory.
Research Partners
Emory’s schools, centers, and scientists are involved in numerous collaborative research partnerships that extend beyond the university and involve academic institutions, government agencies, industry, and nonprofit organizations. These partnerships greatly enrich Emory’s research enterprise, providing new ideas, funding opportunities, and technology transfer collaborations.
Georgia Clinical and Translational Science Alliance
Georgia CTSA unites the strengths of its academic partners, Emory University, Morehouse School of Medicine, the Georgia Institute of Technology, and the University of Georgia (UGA). It is one of 64 clinical and translational science programs at major academic medical centers across the country and the only one in Georgia.
GCTSA WebsiteGeorgia Tech
For more than 20 years, Emory and Georgia Tech have partnered in one of the leading bioengineering and biomedical research and educational programs in the nation, the Wallace H. Coulter Department of Biomedical Engineering, and now have collaborations in regenerative medicine, nanotechnology, bioinformatics, predictive health, safe water, vaccine development, robotics, and clinical trials.
Emory–GA Tech PartnershipGeorgia Research Alliance
Georgia Research Alliance recruits world-class scientists to Georgia universities as GRA Eminent Scholars; invests in state-of-the-art research technology for university labs; fuels the commercialization of university-based discoveries and inventions; and forges and strengthens alliances among universities and industry to make Georgia more economically competitive.
GRA website